Antioxidants Hydroxytyrosol and Vitamin E for Pediatric NAFLD

Valerio Nobili, MD; Antonella Mosca, MD

Disclosures

February 20, 2019

Case Presentation

Source: Alamy

A 14-year-old boy who is obese (body mass index, 27.5 kg/m2) presents with severe hepatic steatosis, as shown on ultrasound imaging.

Relevant laboratory values are as follows:

  • Hypertransaminasemia alanine transaminase, 188 U/L

  • Aspartate aminotransferase, 85 U/L

  • Homeostasis model assessment of insulin resistance, 5.4

  • Triglycerides, 210 mg/dL (>95th percentile)

  • Low-density lipoprotein, 110 mg/dL (>95th percentile)

  • High-density lipoprotein, 28 mg/dL (<5th percentile)

These results indicate that this boy also has hyperinsulinemia and dyslipidemia.

On the basis of these results, and after excluding all other causes of fatty liver, a liver biopsy was performed; this is in accordance with guidelines issued by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition.[1]

The child was diagnosed with nonalcoholic steatohepatitis (NASH), as determined by a nonalcoholic fatty liver disease (NAFLD) Activity Score (NAS) of 7. Other notable findings included:

  • Steatosis, 3

  • Lobular inflammation, 2

  • Portal inflammation, 2

  • Ballooning, 2

  • Fibrosis, 1

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....